Abstract: Oxazolidinones having structures represented by structural formula I, preparation methods therefor, and pharmaceutical uses thereof, in particular an application of said compounds and salts or compositions thereof in the treatment of a bacterial infection. In the formula: R1 is a methyl group, an ethyl group, a propyl group, a cyclopropyl group, or a vinyl group; R2 is F; and R3 is F, CH3, C2H5, CF3, CHF2, CH2F, or a cyclopropyl group.

Abstract: Provided is a thiobenzopyran-based compound of Formula I and its pharmaceutically acceptable salt, and its use in the preparation of drugs for the treatment of rheumatoid arthritis, wherein X is selected from oxygen, sulfur, —SO—, and —SO2—; Y is a sulfur atom and Z is H, Na, or K. Through preliminary tests of anti-inflammatory activity, compounds of formula I have anti-rheumatoid arthritis effects.

Abstract: The present disclosure discloses an expectorant compound, and specifically discloses compounds represented by formula I and formula II, pharmaceutically acceptable salts or tautomers thereof.

Abstract: Provided is a thiobenzopyran-based compound of Formula I and its pharmaceutically acceptable salt, and its use in the preparation of drugs for the treatment of rheumatoid arthritis, wherein X is selected from oxygen, sulfur, —SO—, and —SO2—; Y is a sulfur atom and Z is H, Na, or K. Through preliminary tests of anti-inflammatory activity, compounds of formula I have anti-rheumatoid arthritis effects.

Abstract: Disclosed herein is a method of detecting the presence of a target analyte in a sample. Disclosed herein are also a system, an article, and a kit for detecting the presence of a target analyte in a sample. Disclosed herein is also the use of the system, or the article, or the kit for biomolecule, bioorganelle, bioparticle, cell and microorganism detection.

Abstract: Disclosed herein is a method of detecting the presence or absence of an analyte in a test sample, based on the use of motion resistant particle for example non-magnetic particle coated with first sensing element for the analyte and force driven particle for example superparamagnetic particle coated with a second sensing element for the analyte so as to form a motion resistant particle-analyte-force driven particle conjugate. A viscous medium is added to the mixture and a force such as magnetic force is applied to provide separation of the conjugate for quantification. Disclosed herein are also a sensing kit, a system for detecting the presence or absence of an analyte in a test sample and the use of the kit or the system thereof.

Abstract: Oxazolidinones having structures represented by structural formula I, preparation methods therefor, and pharmaceutical uses thereof, in particular an application of said compounds and salts or compositions thereof in the treatment of a bacterial infection. In the formula: R1 is a methyl group, an ethyl group, a propyl group, a cyclopropyl group, or a vinyl group; R2 is F; and R3 is F, CH3, C2H5, CF3, CHF2, CH2F, or a cyclopropyl group.

Abstract: The present disclosure discloses an expectorant compound, and specifically discloses compounds represented by formula I and formula II, pharmaceutically acceptable salts or tautomers thereof.

Abstract: There is provided a method for geometrical reconstruction of an internal anatomical structure using at least one processor based on a set of contours derived from the internal anatomical structure, the set of contours including a first subset of long-axis contours obtained based on a first set of long-axis images of the internal anatomical structure. The method includes: adjusting the set of contours, comprising adjusting the first subset of long-axis contours to correct for motion artefacts in the first set of long-axis images; and deforming a template three-dimensional (3D) surface mesh preconfigured for the internal anatomical structure's type into a deformed 3D surface mesh based on the adjusted set of contours to obtain the geometrical reconstruction of the internal anatomical structure. In particular, the internal anatomical structure is a heart. There is also provided a corresponding system for geometrical reconstruction of an internal anatomical structure.

Abstract: A method for efficiently preparing ferrate based on nascent state interfacial activity. The method is as follows: (a) preparing nascent iron solution; (b) adding an oxidizing agent to the iron solution of step (a); (c) adding alkali solution or alkali particles to the mixed solution of step (b), mixing by stirring, and carrying out solid-liquid separation; (d) adding a stabilizing agent to the liquid separated out in step (c), and thus obtaining ferrate solution. The yield is 78-98%. The prepared ferrate solution is stable and can be stored for 3-15 days.

Abstract: There is provided a method for geometrical reconstruction of an internal anatomical structure using at least one processor based on a set of contours derived from the internal anatomical structure, the set of contours including a first subset of long-axis contours obtained based on a first set of long-axis images of the internal anatomical structure. The method includes: adjusting the set of contours, comprising adjusting the first subset of long-axis contours to correct for motion artefacts in the first set of long-axis images; and deforming a template three-dimensional (3D) surface mesh preconfigured for the internal anatomical structure's type into a deformed 3D surface mesh based on the adjusted set of contours to obtain the geometrical reconstruction of the internal anatomical structure. In particular, the internal anatomical structure is a heart. There is also provided a corresponding system for geometrical reconstruction of an internal anatomical structure.

Abstract: A method for efficiently preparing ferrate based on nascent state interfacial activity. The method is as follows: (a) preparing nascent iron solution; (b) adding an oxidizing agent to the iron solution of step (a); (c) adding alkali solution or alkali particles to the mixed solution of step (b), mixing by stirring, and carrying out solid-liquid separation; (d) adding a stabilizing agent to the liquid separated out in step (c), and thus obtaining ferrate solution. The yield is 78-98%. The prepared ferrate solution is stable and can be stored for 3-15 days.

Abstract: A method for efficiently preparing ferrate based on nascent state interfacial activity. The method is as follows: (a) preparing nascent iron solution; (b) adding an oxidizing agent to the iron solution of step (a); (c) adding alkali solution or alkali particles to the mixed solution of step (b), mixing by stirring, and carrying out solid-liquid separation; (d) adding a stabilizing agent to the liquid separated out in step (c), and thus obtaining ferrate solution. The yield is 78-98%. The prepared ferrate solution is stable and can be stored for 3-15 days.

Abstract: A preparation method for a composite ferrate reagent. 1, Weigh raw materials; 2, evenly mix a ferric salt, an activating agent and an alkali maintaining agent and heat the mixture; 3, add an oxidant solution; and 4, cool and mix the solution with water. The technical problems of high energy consumption, low yield and poor ferrate product stability of the existing method for preparing ferrate are solved. The obtained product can be stably stored, and the yield of the ferrate reaches 60% to 95%.

Abstract: A method of synthesizing ferrate, which includes the steps of: (a) weighing and obtaining iron salts, activating agents, alkalinizing agents and oxidizing agents solution; (b) mixing uniformly the iron salts, the activating agents and the alkalinizing agents, heating to 30˜398° C. and maintaining for 1 min˜60 min to obtain a mixture; (c) adding the oxidizing agents solution to the mixture with an adding time of less than 10 minutes, then obtaining a precursor; and (d) natural cooling the precursor, then mixing the precursor with water and stirring evenly to obtain a final product of ferrate, wherein a volume ratio of the precursor and the water is 1:1˜5. The method involves low power consumption, low temperature, low explosion risk, non-complicated steps and procedures, short synthetic time and high ferrate conversion efficiency. The method produces ferrate of high yield and good stability, and is suitable for producing ferrate composite pharmaceuticals in industrialized mass production.

Abstract: A method for efficiently preparing ferrate based on nascent state interfacial activity. The method is as follows: (a) preparing nascent iron solution; (b) adding an oxidizing agent to the iron solution of step (a); (c) adding alkali solution or alkali particles to the mixed solution of step (b), mixing by stirring, and carrying out solid-liquid separation; (d) adding a stabilizing agent to the liquid separated out in step (c), and thus obtaining ferrate solution. The yield is 78-98%. The prepared ferrate solution is stable and can be stored for 3-15 days.

Abstract: A preparation method for a composite ferrate reagent. 1, Weigh raw materials; 2, evenly mix a ferric salt, an activating agent and an alkali maintaining agent and heat the mixture; 3, add an oxidant solution; and 4, cool and mix the solution with water. The technical problems of high energy consumption, low yield and poor ferrate product stability of the existing method for preparing ferrate are solved. The obtained product can be stably stored, and the yield of the ferrate reaches 60% to 95%.

Abstract: A method of synthesizing ferrate, which includes the steps of: (a) weighing and obtaining iron salts, activating agents, alkalinizing agents and oxidizing agents solution; (b) mixing uniformly the iron salts, the activating agents and the alkalinizing agents, heating to 30˜398° C. and maintaining for 1 min˜60 min to obtain a mixture; (c) adding the oxidizing agents solution to the mixture with an adding time of less than 10 minutes, then obtaining a precursor; and (d) natural cooling the precursor, then mixing the precursor with water and stirring evenly to obtain a final product of ferrate, wherein a volume ratio of the precursor and the water is 1:1˜5. The method involves low power consumption, low temperature, low explosion risk, non-complicated steps and procedures, short synthetic time and high ferrate conversion efficiency. The method produces ferrate of high yield and good stability, and is suitable for producing ferrate composite pharmaceuticals in industrialized mass production.